Andrew J Yee

29PUBLICATIONS
86CO-AUTHORS
Haematological tumoursMedical molecular engineering of nucleic acids and proteinsMedical biotechnology diagnostics (incl. biosensors)Medical infection agents (incl. prions)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (29)

|Apr 22, 2026
Validation and refinement of the new Consensus Genomic Staging (CGS) of high-risk multiple myeloma (HRMM) in relapsed and refractory patients treated with BCMA CAR-T.

|Apr 08, 2026
Daratumumab in high-risk MGUS and low-risk smoldering myeloma: results of the Phase II D-PRISM study.

Omar Nadeem, Michelle P Aranha, Robert A Redd

|Jan 27, 2026
Ruxolitinib for ciltacabtagene autoleucel-associated refractory diarrhea.

Viktoria Blumenberg, Filippo Birocchi, Angela Shih

|Sep 08, 2025
Clinical applications of mass spectrometry in multiple myeloma.

Benjamin A Derman, Andrew J Yee

|Jun 05, 2025
Prospective study of immunogenicity to SARS-CoV-2 booster vaccines in multiple myeloma and Waldenström macroglobulinemia.

Andrew R Branagan, Clifton Mo, Matthew Lei

|Mar 31, 2025
Cyclophosphamide mitigates non-ICANS neurotoxicities following ciltacabtagene autoleucel treatment.

Viktoria Blumenberg, Benjamin R Puliafito, Charlotte E Graham

Pageof 5

Frequent Collaborators

11 joint publications

Andrew R Branagan

5 joint publications

Diana D Cirstea

4 joint publications

Marcela V Maus

4 joint publications

Jacob P Laubach